Medical history has recently been made in a New York City hospital. This month, 21-year-old Sebastien Beauzile became the ...

Sebastien Beauzile, 21, is the first New Yorker to have received the breakthrough Lyfgenia treatment, according to the New ...

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Scientists say they have identified a potential new gene target that could be edited to treat sickle cell disease, an ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that ...

A machine learning model generated by a team from the European Society for Blood and Marrow Transplantation (EBMT) ...

Mar. 14, 2025 — Researchers have found that proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over time. The research, could potentially ...

Villanova football will host its 17th annual Get in the Game Bone Marrow Drive on April 2 from 10 a.m. to 3 p.m. in the ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

Abu Dhabi Biobank has launched private cord blood banking services, offering expectant families with an affordable, ...